China Pharma Holdings (CPHI) Leases (2018 - 2025)
China Pharma Holdings' Leases history spans 8 years, with the latest figure at $181828.0 for Q4 2025.
- For Q4 2025, Leases rose 374.77% year-over-year to $181828.0; the TTM value through Dec 2025 reached $181828.0, up 374.77%, while the annual FY2025 figure was $181828.0, 374.77% up from the prior year.
- Leases reached $181828.0 in Q4 2025 per CPHI's latest filing, down from $197851.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $197851.0 in Q3 2025 to a low of $19176.0 in Q1 2025.
- Average Leases over 5 years is $97256.7, with a median of $97006.0 recorded in 2024.
- Peak YoY movement for Leases: plummeted 81.52% in 2023, then surged 390.25% in 2024.
- A 5-year view of Leases shows it stood at $127958.0 in 2021, then tumbled by 69.49% to $39046.0 in 2022, then skyrocketed by 198.65% to $116610.0 in 2023, then tumbled by 67.16% to $38298.0 in 2024, then surged by 374.77% to $181828.0 in 2025.
- Per Business Quant, the three most recent readings for CPHI's Leases are $181828.0 (Q4 2025), $197851.0 (Q3 2025), and $19176.0 (Q1 2025).